BCAB

BioAtla, Inc.

OTC· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001826892 Biotech & Drug Discovery

$1.71 +0.48 (+39.02%)

Oct 23 4:00 PM ET · prev $1.23

Market cap

$2.9M

Nano cap

1 year

−95.5%

from $38.00 · Oct 24

30 days

+12.5%

from $1.52

52-week range

$1.08–61.00

−97% from high · low Sep 1

Avg volume 20D

6.3K

Sep 30 spike 16.7K

Short interest

75.6K

≈4.5% of shares · −19.7%

Days to cover

1.4

at average volume

Insider net

no open-market trades · 12 mo

New fund stakes

Q1 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BEARISH 3 reports · 90 days

Balance 3 bearish · 0 bullish oldest → newest, height = score

Avg score

·High conf. 3/3 ·Next Earnings date, Nov 11, 2026

Strongest BEARISH BioAtla, a clinical-stage biopharmaceutical company developing conditionally active biologics (CABs) for…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Mar 2 BioAtla announced a strategic review to explore asset sales, partner…
R Mar 31 BioAtla reported Q4 2025 financial results with a net loss of $9.8 m…
X Aug 14 Short interest jumps 31.7% to 138.9K
R Aug 28 BioAtla received final delisting notice from Nasdaq on August 26, 20…
X Aug 31 Short interest jumps 47.0% to 204.1K
X Sep 15 Short interest falls 53.9% to 94.1K
R Oct 20 BioAtla, a clinical-stage biopharmaceutical company developing condi…
R Oct 20 BioAtla entered into a new Standby Equity Purchase Agreement (SEPA)…

Signal stack

Where each data set points today.

InsidersNO TRADES

No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
InstitutionsMIXED

Q1 2026: 4 added (0 new), 3 trimmed or exited.
Short sellersCOVERING

Short interest −19.7% to 75.6K shares. 1.4 days to cover, ≈4.5% of shares.
TrendDOWNTREND

5% below its 50-day average.

Who's buying

13F· Q1 2026

new positions

exits

Fund	Move	Shares	Value
MILLENNIUM MANAGEMENT LLC	DOUBLED	2,756,674	$443.8K
GEODE CAPITAL MANAGEMENT, LLC	ADD	689,182	$111.0K
RENAISSANCE TECHNOLOGIES LLC	TRIM	510,514	$82.2K
UBS Group AG	ADD	375,569	$60.5K
SIMPLEX TRADING, LLC	TRIM	73,901	$11.9K
MORGAN STANLEY	ADD	55,426	$8.9K
JANE STREET GROUP, LLC	NEAR_EXIT	23,142	$3.7K
MILLENNIUM MANAGEMENT LLC	DOUBLED	762,394	$432.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Aug 2025

Recent actions

Date	Firm	Action	Rating
Aug 13, 2025	JMP Securities DOWNGRADE	DOWNGRADE	Market Perform
Mar 31, 2025	Citizens Capital Markets MAINTAIN	MAINTAIN	Market Outperform
Mar 31, 2025	HC Wainwright & Co. REITERATE	REITERATE	Neutral
Nov 13, 2024	HC Wainwright & Co. DOWNGRADE	DOWNGRADE	Neutral
Sep 16, 2024	JMP Securities REITERATE	REITERATE	Market Outperform
May 23, 2024	JMP Securities MAINTAIN	MAINTAIN	Market Outperform

Insider ledger

Form 4

open-market buys or sells · 12 mo

Date	Insider	Type	Value
Aug 31, 2026	Sievers Eric Chief Medical Officer	TAX W/H	$226.46
Aug 31, 2026	Vasquez Christian Chief Financial Officer	TAX W/H	$119.99
Aug 31, 2026	SHORT JAY M PHD Chief Executive Officer	TAX W/H	$437.71
May 31, 2026	Vasquez Christian Chief Financial Officer	TAX W/H	$322.26
May 31, 2026	Sievers Eric Chief Medical Officer	TAX W/H	$526.62
May 31, 2026	SHORT JAY M PHD Chief Executive Officer	TAX W/H	$1.0K
Mar 12, 2026	SHORT JAY M PHD Chief Executive Officer	TAX W/H	$107.35
Mar 11, 2026	SHORT JAY M PHD Chief Executive Officer	AWARD	430,000 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data — subscribers only
Next Q	🔒 Fresh data — subscribers only
Current FY	🔒 Fresh data — subscribers only
Next FY	🔒 Fresh data — subscribers only